Regulation - Sanofi, Dermatologicals

Filter

Current filters:

SanofiDermatologicals

Popular Filters

Sanofi and Regeneron’s dupilumab gets Breakthrough designation from FDA

20-11-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to French pharma major…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Back to top